当前位置:首页 - 行情中心 - 仟源医药(300254) - 财务分析 - 现金流量表

仟源医药

(300254)

  

流通市值:29.57亿  总市值:33.52亿
流通股本:2.26亿   总股本:2.56亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金212,465,637.45791,404,089567,545,035.96366,156,378.93
  收到的税费返还-1,086,813.441,086,813.441,086,813.44
  收到其他与经营活动有关的现金9,795,250.0341,340,136.9617,271,486.5413,543,051.58
  经营活动现金流入小计222,260,887.48833,831,039.4585,903,335.94380,786,243.95
  购买商品、接受劳务支付的现金55,488,886.34152,789,255.1269,952,004.4947,287,758.59
  支付给职工以及为职工支付的现金56,319,385.28179,902,706.01129,851,459.8894,050,773.31
  支付的各项税费26,557,575.53126,371,971.2392,437,962.2861,742,598.47
  支付其他与经营活动有关的现金62,791,612.4277,999,234.81218,250,055.43155,221,703.02
  经营活动现金流出小计201,157,459.55737,063,167.17510,491,482.08358,302,833.39
  经营活动产生的现金流量净额21,103,427.9396,767,872.2375,411,853.8622,483,410.56
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,239,126.432,360,334.01--
  处置固定资产、无形资产和其他长期资产收回的现金净额576,328352,679121,97957,480
  投资活动现金流入小计1,815,454.432,713,013.01121,97957,480
  购建固定资产、无形资产和其他长期资产支付的现金8,055,327.5434,315,048.8428,643,263.6618,275,121.46
  投资支付的现金147,410,43860,289,231.0460,289,231.0460,289,231.04
  投资活动现金流出小计155,465,765.5494,604,279.8888,932,494.778,564,352.5
  投资活动产生的现金流量净额-153,650,311.11-91,891,266.87-88,810,515.7-78,506,872.5
三、筹资活动产生的现金流量:
  吸收投资收到的现金-43,960,00043,960,000-
  取得借款收到的现金112,500,000238,300,000150,800,00095,000,000
  收到其他与筹资活动有关的现金65,000,00049,000,00048,000,000-
  筹资活动现金流入小计177,500,000331,260,000242,760,00095,000,000
  偿还债务支付的现金53,009,470.13285,640,529.87223,600,00077,300,000
  分配股利、利润或偿付利息支付的现金4,126,152.5418,967,833.4415,152,157.7910,163,757.83
  支付其他与筹资活动有关的现金11,527,447.7319,723,458.3311,151,388.458,622,425
  筹资活动现金流出小计68,663,070.4324,331,821.64249,903,546.2496,086,182.83
  筹资活动产生的现金流量净额108,836,929.66,928,178.36-7,143,546.24-1,086,182.83
五、现金及现金等价物净增加额-23,709,953.5811,804,783.72-20,542,208.08-57,109,644.77
  加:期初现金及现金等价物余额161,311,824.68149,507,040.96149,507,040.96149,507,040.96
  期末现金及现金等价物余额137,601,871.1161,311,824.68128,964,832.8892,397,396.19
补充资料:
  净利润-56,437,313.63-16,333,500.92
  资产减值准备-8,035,871.74--1,421,832.58
  固定资产和投资性房地产折旧-34,550,985.97-17,667,451.27
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-34,550,985.97-17,667,451.27
  无形资产摊销-17,405,407.76-8,666,376.14
  长期待摊费用摊销-1,994,161.32-584,155.89
  处置固定资产、无形资产和其他长期资产的损失--8,941,963.33--7,895,012.66
  固定资产报废损失-428,698.9-131,459.11
  公允价值变动损失-18,934,476--
  财务费用-23,082,774.12-11,923,412.63
  投资损失--3,971,475.89--113,156.56
  递延所得税--3,120,815.62-1,836,311.58
  其中:递延所得税资产减少--1,612,555.62-3,780,677.38
    递延所得税负债增加--1,508,260--1,944,365.8
  存货的减少--2,296,496.87--16,245,751.85
  经营性应收项目的减少--40,668,684.56--38,335,457.27
  经营性应付项目的增加--36,673,520.08-17,982,630.83
  其他-24,166,202.38-7,641,952.53
  不涉及现金收支的投资和筹资活动金额其他项目-0--
  现金的期末余额-161,311,824.68-92,397,396.19
  减:现金的期初余额-149,507,040.96-149,507,040.96
  现金及现金等价物的净增加额-11,804,783.72--57,109,644.77
公告日期2026-04-282026-04-282025-10-302025-08-26
审计意见(境内)标准无保留意见
TOP↑